News Articles
- 6/30/09
Building today's platform company, Guido Lanza, BioEntrepreneur - 3/26/08
Numerate's Small-Molecule Drug Engine Yields Pipeline, Partners, Jennifer Boggs, BioWorld Today - 3/1/08
Scientists ganging up on hepatitis C, David Hutton, Drug Discovery News - 2/12/08
“Drug engineer” Numerate rises from the ashes of Pharmix, David P. Hamilton, VentureBeat
Press Releases
- 3/18/09
Numerate Awarded Phase 1 NIH Grant to Support Design of New Therapies for Celiac Disease - 3/18/09
Numerate Closes $5.5 Million Series B Financing - 11/18/08
Numerate Completes $4 Million Series A Financing - 2/12/08
Numerate Completes Integration of Pharmix Drug Engineering™ Process;
Drug Pipeline Also Acquired - 2/11/08
Presidio Pharmaceuticals and Numerate Announce Research Collaboration to Identify Improved Hepatitis C Therapeutics
